Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.
about
Pharmacodynamics of ampicillin-sulbactam in an in vitro infection model against Escherichia coli strains with various levels of resistance.Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactions.Use of a predictor panel to evaluate susceptibility test methods proposed for piperacillin-tazobactam.Response of enteric gram-negative bacteria to disks containing 20 micrograms each of ampicillin and sulbactam.Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing
P2860
Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Use of a predictor panel to ev ...... hods for ampicillin-sulbactam.
@ast
Use of a predictor panel to ev ...... hods for ampicillin-sulbactam.
@en
type
label
Use of a predictor panel to ev ...... hods for ampicillin-sulbactam.
@ast
Use of a predictor panel to ev ...... hods for ampicillin-sulbactam.
@en
prefLabel
Use of a predictor panel to ev ...... hods for ampicillin-sulbactam.
@ast
Use of a predictor panel to ev ...... hods for ampicillin-sulbactam.
@en
P2860
P356
P1476
Use of a predictor panel to ev ...... hods for ampicillin-sulbactam.
@en
P2093
Bradford PA
Sanders CC
P2860
P304
P356
10.1128/AAC.37.2.251
P407
P577
1993-02-01T00:00:00Z